Skip to main content
Log in

Evaluation of Toxicological Hazards from Medical Radioiodine Administration

  • CDC Toxicology Report
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Notes

  1. See Example Scenario B for further explanation on the use of the gamma constant.

  2. The occupancy factor of 0.25 implies that a person is present 25 % of the time at a certain distance from a source of radiation. The 5 mSv standard is based on a number of factors such as the occupancy factor, inputted into specific equations. Please see NUREG-1556, volume 9, revision 2 [9], for further guidance on these.

  3. See calculations under Example Scenario A for an in-depth explanation on the use of the decay equation.

  4. The 5 mSv and 33 mCi standard are based on a number of factors inputted into specific equations. Please see NUREG-1556, volume 9, revision 2 [9], for further guidance on these factors and the potential variance of patient-specific release rates.

  5. Dose equivalence rate is different from exposure rate in that it takes into account the biological effect of different types of radiation. Exposure rate can be directly measured or determined from the radionuclide of interest and its activity.

References

  1. Shackett P (2009) Nuclear medicine technology: procedures and quick reference, 2nd edn. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, pp 492–493

    Google Scholar 

  2. Mayo Clinic (2011) Sodium iodide I 131 (oral route). http://www.mayoclinic.com/health/drug-information/DR601253. Accessed 20 Aug 2013

  3. Balon HR, Silberstein EB, Meier DA, et al. (2006) Society of Nuclear Medicine procedure guideline for thyroid uptake measurement. http://www.interactive.snm.org/docs/Thyroid%20Uptake%20Measure%20v3%200.pdf. Accessed 25 Aug 2013

  4. U.S. EPA (2012) Iodine. http://www.epa.gov/radiation/radionuclides/iodine.html. Accessed 20 Aug 2013

  5. Shleien B, Birky BK, Slaback LAJ, Birky B, Slaback LA (1998) Health physics & radiological health handbook, 3rd edn. Lippincott Williams & Wilkins, Baltimore

    Google Scholar 

  6. Health Physics Society. (2013) Regulatory dose limits. http://www.hps.org/publicinformation/ate/faqs/regdoselimits.html. Accessed 4 May 2014

  7. US NRC (2013) § 35.75 Release of individuals containing unsealed byproduct material or implants containing byproduct material. http://www.nrc.gov/reading-rm/doc-collections/cfr/part035/part035-0075.html. Accessed 4 May 2014

  8. US NRC (2013) § 20.1301 Dose limits for individual members of the public. http://www.nrc.gov/reading-rm/doc-collections/cfr/part020/part020-1301.html. Accessed 4 May 2014

  9. Howe DB, Beardsley M, Bakhsh SR (2008) Consolidated guidance about materials licenses. Program-specific guidance about medical uses licenses (NUREG-1556, volume 9, revision 2). http://www.pbadupws.nrc.gov/docs/ML0734/ML073400289.pdf. Accessed 4 May 4, 2014

  10. Karesh S, Lipps M (2012) Half lives: physical, biological and effective. http://www.nucmedtutorials.com/dwhalf/effective.html. Accessed 21 Sep 2013

  11. US FDA (2009) What are the radiation risks from CT? http://www.fda.gov/radiation-emittingproducts/radiationemittingproductsandprocedures/medicalimaging/medicalx-rays/ucm115329.htm. Accessed 21 Sep 2013

  12. National Council on Radiation Protection & Measurements (2009) NCRP report no. 160, ionizing radiation exposure of the population of the United States. http://www.ncrponline.org/Publications/Press_Releases/160press.html. Accessed 4 June 2014

  13. Sisson JC, Freitas J, McDougall IR et al (2011) Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid 21(4):335–346

    Article  PubMed  Google Scholar 

  14. US NRC (2009) 10 CFR 20.1003 definitions. http://www.nrc.gov/reading-rm/doc-collections/cfr/part020/part020-1003.html. Accessed 28 Aug 2013

  15. UNSCEAR. UNSCEAR 2006 report vol. I: report to the general assembly, scientific annexes A and B. http://www.unscear.org/unscear/en/publications/2006_1.html. Accessed 11 Nov 2013

  16. US EPA Agency (2012) Radiation protection. http://www.epa.gov/radiation/topics.html. Accessed 25 Aug 2013

  17. NDT Education Resource Center (2012) Radiographic inspection—formula based on Newton’s inverse square law. http://www.ndt-ed.org/GeneralResources/Formula/RTFormula/InverseSquare/InverseSquareLaw.htm. Accessed 25 Aug 2013

  18. Stanford Dosimetry. RADAR—the radiation dose assessment resource. http://www.doseinfo-radar.com/RADARDoseRiskCalc.html. Accessed 4 May 2014

  19. International Commission on Radiological Protection (2004) Release of patients after therapy with unsealed radionuclides. Annals ICRP 34(2):v-vi, 1–79

    Google Scholar 

  20. Leslie WD, Havelock J, Palser R, Abrams DN (2002) Large-body radiation doses following radioiodine therapy. Nucl Med Comm 23(11):1091–7

    Article  CAS  Google Scholar 

  21. Mathieu I, Caussin J, Smeesters P, Wambersie A, Beckers C (1999) Recommended restrictions after 131I therapy: measured doses in family members. Health Phys 76(2):129–36

    Article  CAS  PubMed  Google Scholar 

  22. Zanzonico PB (1997) Radiation dose to patients and relatives incident to 131I therapy. Thyroid 7(2):199–204

    Article  CAS  PubMed  Google Scholar 

  23. Barrington SF, O’Doherty MJ, Kettle AG, Thomson WH, Mountford PJ, Burrell DN, Farrell RJ, Batchelor S, Seed P, Harding LK (1999) Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. Eur J Nucl Med 26(7):686–92

    Article  CAS  PubMed  Google Scholar 

  24. Oak Ridge Institute for Science and Education. Radiation dose estimates and other compendia. http://www.orise.orau.gov/reacts/resources/dose-estimates.aspx. Accessed 4 June 2014

Download references

Acknowledgments

The authors acknowledge the following individuals for their contributions to this paper: Mr. Jim Hardeman, Georgia Poison Center, and Dr. Adam Pomerleau and Mr. John Dixon, Centers for Disease Control and Prevention.

Conflict of Interest

None

Sources of Funding

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Miriam Van Dyke.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Van Dyke, M., Punja, M., Hall, M.J. et al. Evaluation of Toxicological Hazards from Medical Radioiodine Administration. J. Med. Toxicol. 11, 96–101 (2015). https://doi.org/10.1007/s13181-014-0412-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-014-0412-5

Keywords

Navigation